OpenVSafe by OpenVAERS
Search V-safe

864-27824-71695

2 vaccinations 3 coded responses 20 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
630 / MO
Registered
2020-12-19
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-19
    Registered in v-safe
  3. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Diarrhea
    Adult check-in
  4. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache
    Adult check-in
  5. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-25
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-01
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  11. 2021-01-06
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Swelling of eyelid — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Axillary lymphadenopathy & left upper eyelid swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary lymphadenectomy, Swelling of eyelid — Feeling: Good
    Free text: Left axillary lymphadenopathy, left eyelid swelling-improving
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-01-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2022-01-08
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school
    Free text: COVID infection. Pregnancy.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-06Pfizer-BioNTech

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-08

Systemic reaction (other): Axillary lymphadenopathy & left upper eyelid swelling

2021-01-09

Systemic reaction (other): Left axillary lymphadenopathy, left eyelid swelling-improving

Release 10 — 12 months, dose 2

2022-01-08

Symptoms: COVID infection. Pregnancy.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDPregnancy · · ✓
SROAxillary lymphadenectomy ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROSwelling of eyelid ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release